Related Experiment Video
Updated: Mar 12, 2026

Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore
Published on: January 21, 2020
Megaloblastic anemia: A common but often neglected cause of pyrexia of unknown origin
Bushra Siddiqui1, Divya Rabindranath1, Shahbaz Habib Faridi2
1Department of Pathology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.
Objective:
The objective was to study megaloblastic anemia as a cause of pyrexia of unknown origin (PUO).
Materials And Methods:
We conducted a study on 15 patients of megaloblastic anemia associated with fever, attending our hospital clinics over a period of 6 months.
Results:
While 11 patients had symptoms suggesting foci of infection and responded well to intravenous antibiotics, 4 patients had neither any evidence of infection nor responded with empirical broad spectrum antibiotic treatment. They were treated with vitamin B12/folate therapy which led to marked improvement in fever within 48 h. Presenting complaints of the patients and severity/duration of fever along with other epidemiological data were also studied in each case.
Conclusion:
The present study led us to conclude that megaloblastic anemia forms an important and reversible cause of fever and should be ruled out in all patients presenting with PUO. This knowledge would help the physicians in adequate and timely management of these patients.
Insights
Megaloblastic anemia can cause fever of unknown origin (FUO). Prompt diagnosis and vitamin B12/folate therapy can effectively resolve fever in these patients.
Area of Science:
- Hematology
- Internal Medicine
- Clinical Diagnostics
Background:
- Fever of unknown origin (FUO) presents a diagnostic challenge.
- Megaloblastic anemia is a condition characterized by large, immature red blood cells.
- The association between megaloblastic anemia and pyrexia needs further investigation.
Purpose of the Study:
- To investigate megaloblastic anemia as a potential cause of pyrexia of unknown origin (PUO).
- To evaluate the response of fever in megaloblastic anemia patients to specific treatments.
Main Methods:
- A study was conducted on 15 patients with megaloblastic anemia and fever.
- Patients were evaluated over a 6-month period in hospital clinics.
- Data on presenting complaints, fever characteristics, and epidemiological factors were collected.
Main Results:
- Eleven patients showed signs of infection and responded to antibiotics.
- Four patients lacked infection evidence and did not respond to antibiotics.
- These four patients experienced significant fever reduction within 48 hours of vitamin B12/folate therapy.
Conclusions:
- Megaloblastic anemia is an important and reversible cause of fever.
- It should be considered in the differential diagnosis of patients with PUO.
- Timely identification and management can improve patient outcomes.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Acute Pyelonephritis I: Introduction
Inborn Errors of Metabolism
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Increased Body Temperature
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...

